+ All Categories
Home > Documents > Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Date post: 11-Jan-2016
Category:
Upload: opa
View: 52 times
Download: 0 times
Share this document with a friend
Description:
Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta & Institute of Health Economics March 4, 2009. Key Messages…. Alberta Diabetes Atlas 2007 provides trends over time, across age and regional variation for DM & related conditions. - PowerPoint PPT Presentation
Popular Tags:
59
Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta & Institute of Health Economics March 4, 2009
Transcript
Page 1: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Jeffrey A. Johnson, PhDStephanie U. Balko, MSc.University of Alberta &

Institute of Health Economics

March 4, 2009

Page 2: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes Atlas 2007 provides trends over time, across age and regional variation for DM & related conditions.

The prevalence & incidence of DM are increasing in Alberta, and especially among older adults.

People with DM have significantly higher rates of CV disease, eye disease, kidney disease, mental health disorders and overall health care use than people without diabetes.

Better primary care can reduce the burden on acute care

Local information will help local planning.

Key Messages…

Page 3: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes- Background Info.Diabetes- Background Info.

Body has difficulty making insulin and/or using the insulin that it produces.

Problematic because insulin is required to move glucose into cells so that it can be used by body tissues and organs.

Without insulin action, glucose remains in blood.

Page 4: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes- Background Info.Diabetes- Background Info.

When glucose remains in the blood, blood glucose levels can rise to dangerously high levels and result in acute complications.

Higher than normal blood glucose levels also can result in long-term organ damage and affect the eyes, kidneys and cardiovascular system.

Diabetic Retinopathy

End-Stage Renal Disease

Cardiovascular Disease

Page 5: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Usually occurs early in life during childhood or adolescence and is managed with insulin.

Accounts for approximately 5% of all diabetes cases.

Type 1 DiabetesType 1 Diabetes

Page 6: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Usually associated with onset after 30-40 years of age; however during the past decade, it has become much more prevalent in younger individuals.

Associated with many complications such as heart problems, kidney problems, eye disease etc.

Thought to be associated with lifestyle factors including physical inactivity and obesity.

Accounts for 95% of all diabetes cases.

Type 2 DiabetesType 2 Diabetes

Page 7: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes - Big Picture, Big BurdenDiabetes - Big Picture, Big Burden

Is a chronic disease affecting more than 7% of Canadians over 20 years of age.

Healthcare costs of patients with diabetes were projected to be in excess of $6 billion in 2006.

As people are getting diabetes earlier in life, they are also getting complications earlier.

Page 8: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &
Page 9: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &
Page 10: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

ADSS – A Public Health Service…ADSS – A Public Health Service…

“Public health surveillance is the ongoing, systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice, closely integrated with the timely dissemination of these data to those who need to know. . . . A surveillance system includes a functional capacity for data collection, analysis and dissemination…”

-CDC Surveillance Update, 1988

Page 11: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Create nationally comparable data: Base epidemiological measures

(incidence, prevalence, mortality) complications health services utilization

Enhance capacity for Diabetes Surveillance Provincial / Territorial Aboriginal communities

Administrative Data

National Diabetes Surveillance System (NDSS)National Diabetes Surveillance System (NDSS)

Page 12: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Mortality

12

Demographic Data

Data SourcesData Sources

Hospital PhysicianInsurance Registry

GPSpecialist

Age

Gender

Location of Residence

Status Aboriginal

Co-Morbidities/Procedures

DM StatusIncident/Prev

DM StatusIncident/Prev

Co-Morbidities/Procedures

Page 13: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

National Diabetes Surveillance System (NDSS)National Diabetes Surveillance System (NDSS)

Page 14: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

ADSSADSS

AHW & IHE/ACHORD partnership Deliverables

Alberta Diabetes Atlas 2007, 2009, 2011

ADSS Newsletter Regular updates and issue-specific focus

ADSS Website Timely, region-specific information

Page 15: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes Atlas 2007Alberta Diabetes Atlas 2007

Acknowledgments

1. Background & Methods

2. Epidemiologic Trends, 1995-2005

3. DM & Health Care Utilization

4. DM & Cardiovascular Disease

5. DM & Lower Limb Amputations

6. DM & Kidney Disease

7. DM & Eye Disease

8. DM & Mental Health

9. DM & First Nations People

10. Key Findings & Policy Options

Glossary

Page 16: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &
Page 17: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes PrevalenceAlberta Diabetes Prevalence(Age-Adjusted Rates)(Age-Adjusted Rates)

Page 18: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes PrevalenceAlberta Diabetes Prevalence(Case Counts)(Case Counts)

Page 19: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes IncidenceAlberta Diabetes Incidence(Case Counts)(Case Counts)

Page 20: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Age-Specific DM Prevalence Rates, 2007Age-Specific DM Prevalence Rates, 2007

Page 21: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Age-Specific DM Prevalence Rates, 1997 and 2007Age-Specific DM Prevalence Rates, 1997 and 2007

>60% Increase

Page 22: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes Prevalence Alberta Diabetes Prevalence Age-Adjusted Rates, 2006Age-Adjusted Rates, 2006

Page 23: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes Prevalence in David ThompsonDiabetes Prevalence in David Thompson(Case Counts)(Case Counts)

Page 24: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Prevalence Rates by Community Prevalence Rates by Community (Age-Adjusted) 2007(Age-Adjusted) 2007

Page 25: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes Prevalence Diabetes Prevalence (Case Counts) 2007(Case Counts) 2007

Page 26: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes Incidence in David ThompsonDiabetes Incidence in David Thompson(Case Counts)(Case Counts)

Page 27: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes Incidence in David ThompsonDiabetes Incidence in David Thompson(Age-Adjusted Rates)(Age-Adjusted Rates)

Page 28: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Incidence Rates by CommunityIncidence Rates by Community (Age-Adjusted) 2007 (Age-Adjusted) 2007

Page 29: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes Incidence by CommunityDiabetes Incidence by Community (Case Counts) 2007(Case Counts) 2007

Page 30: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes & MortalityDiabetes & Mortality(Age-Adjusted Rates)(Age-Adjusted Rates)

Page 31: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &
Page 32: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Physician VisitsPhysician Visits (1995-2005)(1995-2005)

GeneralPractitioners

Specialists*

Page 33: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Physician Visits by RegionPhysician Visits by Region(2005)(2005)

Specialists*

GeneralPractitioners

DTHR Average =9.7

DTHR Average

= 3.2

Page 34: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Emergency Department Visits Emergency Department Visits (Age/Sex Adjusted, 1998-2005)(Age/Sex Adjusted, 1998-2005)

Page 35: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Total Number of ED Visits for People Total Number of ED Visits for People with Diabetes with Diabetes (1998-2005)(1998-2005)

Page 36: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Emergency Department Visits by RegionEmergency Department Visits by Region

(2005)(2005)

DTHR Diabetes Average = 1.7

Page 37: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Hospital DaysHospital Days(Age/Sex Adjusted, 1995-2005)(Age/Sex Adjusted, 1995-2005)

Page 38: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Hospitalization Days by RegionHospitalization Days by Region(Age/Sex Adjusted, 2005)(Age/Sex Adjusted, 2005)

DTHR Diabetes Average = 2.8

Page 39: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &
Page 40: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes & CVDAcute Coronary Syndrome, 1995-2005

Page 41: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes & CVDAcute Coronary Syndrome, 1995-2005

Page 42: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes & CVD Age-Adjusted Rates of Acute Coronary Syndrome by Region, 2005

Page 43: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &
Page 44: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes & Eye DiseaseEye Examinations*, 1995-2005

* Eye examinations by an Ophthalmologist

Page 45: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes & Eye DiseaseEye Examinations*, 2005

* Eye examinations by an Ophthalmologist

Page 46: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes and Special PopulationsDiabetes and Special Populations

Page 47: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Diabetes and First NationsDiabetes and First Nations

Diabetes Prevalence Rate=14.4%

First Nations people living in David

Thompson have among the highest rates of

diabetes – among those FN who are >65 years,

rates are 35%.

Page 48: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Under 20: Crude Diabetes Prevalence Rates by Region, 2005

Average Provincial Rate = 0.23

Page 49: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes Atlas 2007

Other topics included:

DM & Lower Limb Amputation

DM & Kidney Disease- Incidence & prevalence of ESRD- Kidney transplants

DM & Mental Health- Affective disorders- Anxiety disorders- Psychoses (organic & non-organic)- Substance abuse disorders

DM & First Nations People

Page 50: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes Atlas 2007Key Findings & Policy Options

Key Findings & Options:

1. Primary prevention to reduce rising prevalence.

2. Secondary prevention to reduce complications.

3. Enhance Quality of Primary Care.

4. Enhance Access to Primary Care.

5. Recognize mental health burden.

6. Enhanced eye care for diabetes.

7. Diabetes in First Nations People.

8. Enhance scope and depth of DM surveillance.

Page 51: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes Fact Sheet 2008

Page 52: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

ADSS - what is missing…?- what is next…?

Conditions: DM & pregnancy DM & foot disease DM & cancer

New data: Laboratory surveillance Drug Utilization Risk factor surveillance

Page 53: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

How YOU can use the ADSS…How YOU can use the ADSS…

ADSS can be used by the Regions to more accurately assess what the burden of DM and it’s comorbidities are.

ADSS provides important information and specific numbers that can be included in Regional Health Authority business plans/performance reports.

Diabetes is one of the conditions expected in performance reports for all health regions in Alberta.

ADSS can help regions plan and evaluate new programs.

Page 54: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

ADSS Dissemination*ADSS Dissemination*

1. Active dissemination to Regions: Local presentations

Regional Administration MOH/PCNs/DECs Public

2. Ongoing Newsletters

3. ADSS Website

*ADSS Dissemination Sub-Committee: J. Johnson, C. Andres, A. Edwards, K. McLaughlin, R. Lewanczuk

Page 55: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

www.albertadiabetes.ca

Page 56: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

ADSS Website: Search CriteriaADSS Website: Search Criteria

All of Alberta

Regional Health Authority

Sub-Region

Community

Both Sexes

Male

Female

All Ages

20-34 years

35-49 years

50-64 years

65-74 years

75 + years

Rates/Cases from

1995-2005

DM alone or DM & Disease

First Nations Status

Page 57: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

DM Incidence

Primary Prevention Intervention

Control No Intervention

ADSS – Health Research Potential …ADSS – Health Research Potential …

Page 58: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Alberta Diabetes Atlas 2007 provides trends over time, across age and regional variation for DM & related conditions.

The prevalence & incidence of DM are increasing in Alberta, and especially among older adults.

People with DM have significantly higher rates of CV disease, eye disease, kidney disease, mental health disorders and overall health care use than people without diabetes.

Better primary care can reduce the burden on acute care

Local information will help local planning.

Key Messages…

Page 59: Jeffrey A. Johnson, PhD Stephanie U. Balko, MSc. University of Alberta &

Questions…???Questions…???

[email protected]@ualberta.ca

www.ACHORD.ca


Recommended